Biological Activity and Pharmacological Application of Natural Substances in the Treatment and Prevention of Autoimmune Diseases and Infections
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (15 May 2022) | Viewed by 11110
Special Issue Editor
Interests: natural products; pharmacology; immunology; rheumatoid arthritis; medicinal plants; antioxidants; biological models; new generations of drug delivery; functional food
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Natural compounds are evidently powerful candidates for the prevention and treatment of many chronic diseases which are highly prevalent in the current population. The sources of them are not only from plants but also from different animal species. The chemical structure of natural compounds is diverse and no dependent on a specific molecular structure. This Special Issue is focussed on an overview of their ability to modulate and regulate the immune system. In this research field are included all autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, systemic scleroderma, sclerosis multiplex, autoimmune myocarditis, diabetes mellitus type 1, Crohn’s disease, coeliac disease, ulcerative colitis, fibromyalgia, myasthenia gravis, Kawasaki diseases and others. Moreover, immune system is of key importance to combat all infection diseases. Natural substances are effective immunostimulants thus preventing many infection diseases including viral pathogens. Many natural compounds do not have adverse effects as synthetic immunosuppressants, which is of great advantage.
Dr. Katarína Bauerová
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Natural compounds
- Autoimmune diseases
- Infectious diseases
- Pharmacologic treatment
- Pharmacologic prevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.